Fuqiang Wen Selected Research

Disease Progression

1/2022	ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations.
7/2021	Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale.
1/2019	Subgroup Analysis for Chinese Patients Included in the INPULSIS® Trials on Nintedanib in Idiopathic Pulmonary Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fuqiang Wen Research Topics

Disease

40	Chronic Obstructive Pulmonary Disease (COPD) 04/2022 - 02/2012
31	Inflammation (Inflammations) 07/2022 - 01/2008
8	Neoplasms (Cancer) 10/2021 - 01/2014
6	Acute Lung Injury 07/2022 - 12/2012
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2022 - 10/2018
5	Malignant Pleural Effusion 08/2017 - 01/2014
4	Sepsis (Septicemia) 07/2022 - 11/2017
4	Asthma (Bronchial Asthma) 01/2022 - 10/2013
4	Pneumonia (Pneumonitis) 11/2020 - 12/2012
4	Pleural Effusion (Pleural Effusions) 12/2017 - 01/2015
3	Lung Injury 07/2022 - 01/2018
3	Disease Progression 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 06/2021 - 11/2014
3	Hyperplasia 01/2021 - 05/2012
3	Lung Neoplasms (Lung Cancer) 01/2019 - 05/2013
3	Pulmonary Tuberculosis 03/2016 - 01/2010
2	Pulmonary Edema 07/2022 - 10/2018
2	Lung Diseases (Lung Disease) 12/2021 - 11/2016
2	Infections 12/2021 - 10/2018
2	Adenocarcinoma of Lung 10/2021 - 04/2017
2	Emphysema 01/2021 - 10/2019
2	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2020 - 01/2018
2	Chronic Cough 11/2020 - 01/2018
2	Airway Remodeling 04/2020 - 10/2013
2	Edema (Dropsy) 01/2018 - 01/2008
2	Tuberculosis (Tuberculoses) 01/2017 - 01/2010
2	Necrosis 01/2016 - 08/2005
2	Carcinoma (Carcinomatosis) 03/2015 - 07/2007
1	Dyspnea (Shortness of Breath) 01/2022
1	Hyperoxia 12/2021
1	Human Influenza (Influenza) 12/2021
1	Chronic Bronchitis 07/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Mycoplasma Pneumonia 01/2021
1	Bronchitis 11/2020
1	Bronchiolitis 10/2019

Drug/Important Bio-Agent (IBA)

21	SmokeIBA 12/2021 - 08/2005
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
10	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2010
5	GoldIBA 04/2022 - 01/2018
4	CytokinesIBA 07/2022 - 01/2013
4	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 10/2017
4	LipopolysaccharidesIBA 12/2021 - 12/2012
4	Messenger RNA (mRNA)IBA 01/2021 - 12/2012
4	C-Reactive ProteinIBA 01/2019 - 07/2013
4	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2012
4	Receptor for Advanced Glycation End ProductsIBA 10/2018 - 04/2014
3	AntioxidantsIBA 07/2022 - 05/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 02/2015
3	AntigensIBA 01/2021 - 06/2015
3	Interleukin-8 (Interleukin 8)IBA 10/2018 - 12/2012
3	InterleukinsIBA 10/2018 - 01/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 01/2015
3	LigandsIBA 08/2015 - 01/2012
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022 - 01/2015
2	Peptides (Polypeptides)IBA 01/2021 - 01/2010
2	Nucleic AcidsIBA 01/2021 - 05/2015
2	Particulate MatterIBA 11/2020 - 01/2018
2	EndostatinsIBA 01/2020 - 06/2015
2	Circular RNAIBA 10/2019 - 01/2019
2	MucinsIBA 02/2018 - 05/2012
2	FlavonoidsIBA 02/2018 - 04/2015
2	SurvivinIBA 01/2018 - 01/2014
2	Tumor Biomarkers (Tumor Markers)IBA 08/2017 - 04/2017
2	Carcinoembryonic AntigenIBA 08/2017 - 04/2017
2	antigen CYFRA21.1IBA 08/2017 - 04/2017
2	p38 Mitogen-Activated Protein KinasesIBA 01/2017 - 11/2016
2	SilymarinIBA 11/2016 - 04/2015
2	AdiponectinIBA 01/2016 - 09/2015
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2014 - 09/2009
1	Serum AlbuminIBA 07/2022
1	Cysteine (L-Cysteine)FDA Link 07/2022
1	Leucine (L-Leucine)FDA Link 07/2022
1	ThioredoxinsIBA 07/2022
1	fudosteineIBA 07/2022
1	NucleotidesIBA 07/2022
1	PyrinIBA 07/2022
1	CateninsIBA 01/2022
1	prednylidene (Pred)IBA 01/2022
1	GasesIBA 01/2022
1	andrographolideIBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 11/2021
1	Biological ProductsIBA 07/2021
1	Biological FactorsIBA 07/2021
1	mitoquinoneIBA 01/2021
1	AngiopoietinsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Tobacco Smoke Pollution (Passive Smoking)IBA 11/2020
1	CollagenIBA 04/2020
1	Serotonin ReceptorsIBA 04/2020
1	Serotonin (5 Hydroxytryptamine)IBA 04/2020
1	Alcian BlueIBA 04/2020
1	Periodic AcidIBA 04/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020

Therapy/Procedure

3	Therapeutics 12/2021 - 03/2010
1	Drug Therapy (Chemotherapy) 07/2022
1	Punctures 07/2022
1	Ligation 07/2022
1	Activities of Daily Living (ADL) 01/2022
1	Immunotherapy 10/2021